How you forecast, manage and analyze your clinical operations resourcing needs will impact the speed, accuracy and cost of your clinical research. Inefficient resource forecasting of resources creates unnecessary overhead costs, administrative burdens, timeline risks and staff turnover. Join the discussion as we review the advantages and disadvantages of moving capacity management from sponsor to vendor. Forecasting and managing capacity can be burdensome and pull operational teams away from study delivery tasks, but ignoring them can cause over- or under-resourcing, leading to financial and/or operational headaches. Turning forecasting and capacity management over to a vendor or keeping it in-house both have their advantages and disadvantages.
Timothy King, Executive Director, Project Management, FSP, PPD
Timothy King is part of PPD’s functional service partnerships leadership team, and is responsible for clinical operations, project management and study startup FSPs globally. He has been in global medical research since 1990.Message Presenter
Helen Neal, Executive Director, Clinical Monitoring, FSP, PPD
Helen Neal has been as executive director of clinical operations since 2019 and an executive director in global project management since 2017. Overall, she has 27 years of experience in the industry, many of which have been in leadership positions.Message Presenter
Who Should Attend?
Managers and leaders within pharma or biotech who are responsible for making forecasting and hiring decisions (for outsourcing FTES or hourly contractors).
- Operations Leaders
- Clinical Operations
- Resourcing Managers
- Procurement Leads
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our customers include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and more than 24,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.